Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

被引:0
|
作者
Simon Kind
Franziska Büscheck
Doris Höflmayer
Claudia Hube-Magg
Martina Kluth
Maria Christina Tsourlakis
Stefan Steurer
Till S. Clauditz
Andreas M. Luebke
Eike Burandt
Waldemar Wilczak
Andrea Hinsch
David Dum
Sören Weidemann
Christoph Fraune
Burkhard Beyer
Thomas Steuber
Hartwig Huland
Markus Graefen
Margit Fisch
Ronald Simon
Guido Sauter
Thorsten Schlomm
Sarah Minner
Till Eichenauer
机构
[1] University Medical Center Hamburg-Eppendorf,Institute of Pathology
[2] University Medical Center Hamburg-Eppendorf,Department of Urology
[3] University Medical Center Hamburg-Eppendorf,Martini
[4] Universitätsmedizin Berlin,Clinic, Prostate Cancer Center
来源
World Journal of Urology | 2020年 / 38卷
关键词
Prostate cancer; Prognosis; Claudin-1; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2185 / 2196
页数:11
相关论文
共 50 条
  • [21] REDUCED EXPRESSION OF ALPHA-TOCOPHEROL-ASSOCIATED PROTEIN IS ASSOCIATED WITH TUMOR CELL PROLIFERATION AND THE INCREASED RISK OF PROSTATE CANCER RECURRENCE
    Wen, Xingqiao
    Li, Xiaojuan
    JOURNAL OF UROLOGY, 2011, 185 (04): : E57 - E57
  • [22] Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG fusion positive, PTEN deleted prostate cancers
    Tsourlakis, Maria Christina
    Kluth, Martina
    Kleinhaus, Sandra
    Masser, Sawinee
    Burdelski, Christoph
    Huland, Hartwig
    Heinzer, Hans
    Graefen, Markus
    Beyer, Burkhard
    Steurer, Stefan
    Simon, Ronald
    Koop, Christina
    Schlomm, Thorsten
    Sauter, Guido
    Minner, Sarah
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
    Krohn, Antje
    Diedler, Tobias
    Burkhardt, Lia
    Mayer, Pascale-Sophie
    De Silva, Colin
    Meyer-Kornblum, Marie
    Koetschau, Darja
    Tennstedt, Pierre
    Huang, Joseph
    Gerhaeuser, Clarissa
    Mader, Malte
    Kurtz, Stefan
    Sirma, Huesyin
    Saad, Fred
    Steuber, Thomas
    Graefen, Markus
    Plass, Christoph
    Sauter, Guido
    Simon, Ronald
    Minner, Sarah
    Schlomm, Thorsten
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (02): : 401 - 412
  • [24] Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer
    Xu, Ning
    Chen, Hui-Jun
    Chen, Shao-Hao
    Xue, Xue-Yi
    Chen, Hong
    Zheng, Qing-Shui
    Wei, Yong
    Li, Xiao-Dong
    Huang, Jin-Bei
    Cai, Hai
    Sun, Xiong-Lin
    MEDICINE, 2016, 95 (29)
  • [25] Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
    Kang, Ho Won
    Do Jung, Hae
    Lee, Joo Yong
    Kwon, Jong Kyou
    Jeh, Seong Uk
    Cho, Kang Su
    Ham, Won Sik
    Choi, Young Deuk
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (03) : 480 - 484
  • [26] Multi-scale tissue architecture analysis of favorable-risk prostate cancer: Correlation with biochemical recurrence
    Pukl, Miha
    Keyes, Sarah
    Keyes, Mira
    Guillaud, Martial
    Volavsek, Metka
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (05) : 482 - 490
  • [27] Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers
    Luebke, Andreas M.
    Ricken, Wiebke
    Kluth, Martina
    Hube-Magg, Claudia
    Schroeder, Cornelia
    Buescheck, Franziska
    Moeller, Katharina
    Dum, David
    Hoeflmayer, Doris
    Weidemann, Soeren
    Fraune, Christoph
    Hinsch, Andrea
    Wittmer, Corinna
    Schlomm, Thorsten
    Huland, Hartwig
    Heinzer, Hans
    Graefen, Markus
    Haese, Alexander
    Minner, Sarah
    Simon, Ronald
    Sauter, Guido
    Wilczak, Waldemar
    Meiners, Jan
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (02) : 575 - 583
  • [28] Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
    B G Barwick
    M Abramovitz
    M Kodani
    C S Moreno
    R Nam
    W Tang
    M Bouzyk
    A Seth
    B Leyland-Jones
    British Journal of Cancer, 2010, 102 : 570 - 576
  • [29] Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
    Barwick, B. G.
    Abramovitz, M.
    Kodani, M.
    Moreno, C. S.
    Nam, R.
    Tang, W.
    Bouzyk, M.
    Seth, A.
    Leyland-Jones, B.
    BRITISH JOURNAL OF CANCER, 2010, 102 (03) : 570 - 576
  • [30] Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers
    Burdelski, Christoph
    Kleinhans, Sandra
    Kluth, Martina
    Hube-Magg, Claudia
    Minner, Sarah
    Koop, Christina
    Graefen, Markus
    Heinzer, Hans
    Tsourlakis, Maria Christina
    Wilczak, Waldemar
    Marx, Andreas
    Sauter, Guido
    Wittmer, Corinna
    Huland, Hartwig
    Simon, Ronald
    Schlomm, Thorsten
    Steurer, Stefan
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (05) : 1199 - 1206